Mixed Anxiety and Depression
- 1 January 1998
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 9 (4) , 271-280
- https://doi.org/10.2165/00023210-199809040-00003
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With AnxietyJournal of Clinical Psychopharmacology, 1998
- The Use of the Reversible Monoamine Oxidase-A Inhibitor Brofaromine in Social Phobia Complicated by Panic Disorder With or Without AgoraphobiaJournal of Clinical Psychopharmacology, 1994
- A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorderEuropean Neuropsychopharmacology, 1993
- A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patientsActa Psychiatrica Scandinavica, 1993
- Pharmacotherapy of Social PhobiaThe British Journal of Psychiatry, 1992
- The Anti-anxiety and Anti-agitation Effects of Paroxetine in Depressed PatientsInternational Clinical Psychopharmacology, 1992
- MoclobemideDrugs, 1992
- Mixed anxiety and depression.Journal of Abnormal Psychology, 1991
- Recurrent brief depression: a new subtype of affective disorderJournal of Affective Disorders, 1990
- A multicentre double‐blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practiceActa Psychiatrica Scandinavica, 1990